ASLAN Pharmaceuticals Limited (ASLN) Misses Q4 EPS by 48c
Tweet
Share
E-mailGet Alerts ASLN Hot Sheet
Join SI Premium – FREE
ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) reported Q4 EPS of ($0.66), $0.48 worse than the analyst estimate of ($0.18).
For earnings history and earnings-related data on ASLAN Pharmaceuticals Limited (ASLN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Unifi, Inc. (UFI) Misses Q4 EPS by 11c
- Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
